NGeneBio Market Cap

NGeneBio has a market cap or net worth of 31.88 billion as of April 29, 2026. Its market cap has decreased by -4.66% in one year.

Market Cap

31.88B

Enterprise Value

59.08B

Revenue

21.24B

Ranking

n/a

PE Ratio

n/a

Stock Price

1,189.00

Market Cap Chart

Since December 10, 2020, NGeneBio's market cap has decreased from 313.33B to 31.88B, a decrease of -89.83%. That is a compound annual growth rate of -34.58%.

Market Cap History

Date	Market Cap	% Change
Apr 29, 2026	31.88B	-12.80%
Dec 30, 2025	36.56B	12.79%
Dec 30, 2024	32.41B	-54.77%
Dec 28, 2023	71.66B	-38.23%
Dec 29, 2022	116.03B	-42.38%
Dec 30, 2021	201.38B	-46.99%
Dec 30, 2020	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Epibiotech	34.60B
Eutilex.Co.,Ltd	35.32B
Moogene Medi	30.51B
Kainos Medicine	35.56B
MOA Life Plus	36.69B
Poongjeon Pharmacy CO.,LTD.	40.98B
Parataxis Korea	44.13B
J2KBIO	48.59B

Market Cap Rankings